Jennifer Bourland, Evonik & Dr Massimo Alberti, Revivo
Jennifer Bourland, Evonik & Dr Massimo Alberti, Revivo
19 January 2022
The Soul of Business: Singaporean start-up working towards ending animal testing
On the Soul of Business, Claressa Monteiro speaks to Dr Jennifer Bourland, Head of Innovation Domain Cell & Tissue Systems, Evonik and Dr. Massimo Alberti, CEO and Founder, Revivo, on their partnership to develop organ-on-a-chip technology that will revolutionise chemical testing and drug development.
Download the podcast.